| 产品详情 |
| Edit |   |
|---|
| Antigenic Specificity | Epilepsy, Progressive Myoclonus Type 2A, Lafora Disease (Laforin) (EPM2A) (aa 243-331) |
|---|
| Clone | P3F3AT |
|---|
| Host Species | Mouse |
|---|
| Reactive Species | human |
|---|
| Isotype | n/a |
|---|
| Format | unconjugated |
|---|
| Size | 5 µg |
|---|
| Concentration | n/a |
|---|
| Applications | ELISA,Western Blotting (WB) |
|---|
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
|---|
| Description | EPM2A is a dual-specificity phosphatase which associates with polyribosomes. The EPM2A protein may be involved in the regulation of glycogen metabolism. Mutations in the EPM2A gene have been linked to myoclonic epilepsy of LaforaSynonyms: Laforin, Lafora PTPase, LAFPTPase, EPM2A, EPM2, MELF, epilepsy progressive myoclonus type 2A Lafora disease |
|---|
| Immunogen | Anti-human EPM2A mAb, is derived from hybridization of mouse F0 myeloma cells with spleen cells from BALB/c mice immunized with recombinant human EPM2A AA 243-331 |
|---|
| Other Names | TG-B|Tg(TcraK,TcrbK)TG-BFlv|EPM2|MELF|laforin |
|---|
| Gene, Accession # | Gene ID: 7957 |
|---|
| Catalog # | ABIN808863 |
|---|
| Price | |
|---|
| Order / More Info | Epilepsy, Progressive Myoclonus Type 2A, Lafora Disease (Laforin) (EPM2A) (aa 243-331) Antibody from ANTIBODIES-ONLINE GmbH |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|